Researchers conducted a population - based
perspective birth cohort study of 7,046 pregnant women, and categorized subjects into three groups: negative anti-tTG (control), intermediate anti-tTG (just below the clinical cut - off point used to diagnose patients with celiac disease) and positive anti-tTG (highly probable celiac disease patients).